Loading interface...

Mylamin GN Tablet

Manufactured byMACLEODS PHARMACEUTICALS PVT LTD
ContainsGabapentin (400 mg) + Nortriptyline (10 mg)
Description
Mylamin GN Tablet is used for the treatment of neuropathic pain or nerve pain that happens because of damage or changes to nerves. These changes develop over time causing pain or abnormal sensations in the body. Nerve damage can occur due to many disease conditions like diabetes, cancer, spine diseases, thyroid problems and HIV infection. Mylamin GN Tablet relieves nerve pain by stopping the movement of pain signals to the brain. Common side effects of Mylamin GN Tablet are constipation, weight gain, dry mouth, difficulty in urination, dizziness and drowsiness. Do not drive or do anything that requires high mental alertness after taking this tablet. Use it cautiously in people with unusual changes in mood or behaviour as this medicine may lead to suicidal tendencies. You should take Mylamin GN Tablet with or without food and preferably at night. For the ease of remembering, take this tablet around the same time every day. Do not stop the use of this medicine without consulting your doctor.

Side effects

Major & minor side effects for Mylamin GN Tablet

  • Dizziness
  • Uncontrolled eye movements
  • Constipation
  • Dry mouth
  • Lower back pain
  • Drowsiness
  • Weight gain
  • Blurred vision
  • Weakness in arms, hands, legs or feet
  • Breast enlargement
  • Skin rash
  • Difficult or painful urination

Uses of Mylamin GN Tablet

What is it prescribed for?

  • Postherpetic Neuralgia
  • Neuropathic pain
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The onset of action for Mylamin GN Tablet can be observed within 2 to 3 hours of administration. You may start feeling relief from your nerve pain after 2 weeks of use. But, you may have to continue this medicine for 2 to 3 months to see a complete benefit.
  • How long do the effects of this medicine last?
    The effect of Mylamin GN Tablet lasts for about 6 to 8 hours and then you may have to take your next dose as directed by your doctor/pharmacist.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol during therapy with Mylamin GN Tablet increase side effects like dizziness, drowsiness and difficulty in concentration. Avoid the consumption of alcohol while taking this medicine.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for Mylamin GN Tablet.
  • Can this medicine be taken during pregnancy?
    Mylamin GN Tablet is not recommended for use in pregnant women. It is only acceptable for use if there are no alternatives available and upon your doctor's recommendation. All the risks and benefits should be discussed with your doctor before starting this medicine.
  • Can this medicine be taken while breast-feeding?
    Mylamin GN Tablet is not recommended for use in breastfeeding women. It is only acceptable for use if there are no alternatives available and upon your doctor's recommendation. All the risks and benefits should be discussed with your doctor before starting this medicine.

Allergy

Avoid taking Mylamin GN Tablet if you are previously allergic to it. Seek immediate medical attention if you notice any symptoms of serious allergic reactions such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulties, etc.

Heart attack

Mylamin GN Tablet is not recommended for use in people recovering from a recent heart attack due to the increased risk of worsening the condition.
Warnings for special population

Pregnancy

Mylamin GN Tablet is not recommended for use in pregnant women. It is only acceptable for use if there are no alternatives available and upon your doctor's recommendation. All the risks and benefits should be discussed with your doctor before starting this medicine.

Breast-feeding

Mylamin GN Tablet is not recommended for use in breastfeeding women. It is only acceptable for use if there are no alternatives available and upon your doctor's recommendation. All the risks and benefits should be discussed with your doctor before starting this medicine.
General warnings

Skin reactions

Mylamin GN Tablet may cause allergic skin reactions in some people. Seek immediate medical attention if you notice any symptoms such as skin rash, or severe itching/swelling, especially on the face.

Driving or operating machinery

Mylamin GN Tablet may cause dizziness, confusion, or disorientation in some patients. Hence do not perform any activities such as driving or operating machinery if you experience any of these symptoms.

Suicidal tendencies

Patients should be closely monitored for any change in mood or behaviour while using Mylamin GN Tablet as it may lead to suicidal tendencies. Report any mood changes to the doctor immediately so that proper counselling can be performed.

Withdrawal symptoms

Do not stop taking Mylamin GN Tablet even if your pain is relieved; continue using it for the prescribed period of time. If this medicine is stopped suddenly you may experience withdrawal symptoms such as anxiety, sleeping difficulties, excessive sweating, nausea, and vomiting. A gradual dose reduction is recommended before stopping the medicine completely to avoid these reactions.

Surgery

Use of Mylamin GN Tablet is not recommended if you are planning to undergo surgery in the near future.

Weight gain

Mylamin GN Tablet may cause weight gain in some individuals. This medicine can make a person feel more hungry, thereby increasing the chances of putting in more weight. Avoid soft drinks, oily food, chips, cakes, biscuits, sweets and eat a healthy balanced diet by including fruits, vegetables and low-calorie foods.

Liver disease

Mylamin GN Tablet is primarily metabolized (breakdown of medicine to its active form) by the liver. Patients with liver disease need special dose consideration while taking this medicine due to the increased risk of liver damage. Dose adjustment should be done based on the clinical condition.

Use in children

Mylamin GN Tablet is not recommended for use in children.

Sexual problems

Mylamin GN Tablet may cause decreased sexual desire, erectile dysfunction (a condition where a man is unable to achieve and/or maintain a penile erection adequate enough for sexual intercourse) and inability to reach orgasm. Report any such sexual problems to the doctor immediately but do not stop taking this tablet.

Missed Dose

Take the missed dose of Mylamin GN Tablet as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Seek medical emergency in case of an overdose with Mylamin GN Tablet.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol during therapy with Mylamin GN Tablet increase side effects like dizziness, drowsiness and difficulty in concentration. Avoid the consumption of alcohol while taking this medicine.
Interaction with Medicine

Duloxetine

Glimepiride

Ondansetron

Buprenorphine

Metoprolol

Disease interactions

Kidney Disease

Mylamin GN Tablet is filtered by the kidney and moved out of the body through urine. Patients with kidney disease need special dose consideration while taking this medicine due to the increased risk of kidney damage. Dose adjustment should be done based on the clinical condition.

Heart Disease

Mylamin GN Tablet should be used with extreme caution in patients suffering from heart diseases due to the risk of altered blood pressure levels, irregular heart rate, syncope (loss of consciousness), stroke and ECG abnormalities. Close monitoring of heart function, including ECG changes, is necessary while using this medicine.

Pheochromocytoma

Mylamin GN Tablet may alter the effects of catecholamines- hormones made by the adrenal glands. Therefore use this medicine cautiously in patients suffering from Pheochromocytoma- a tumour that usually grows in your adrenal glands, above the kidneys. Treatment with this medicine can increase the blood pressure in such patients.

Diabetes Mellitus

Long-term therapy with Mylamin GN Tablet in patients with diabetes is reported to alter the blood glucose levels. Monitor blood glucose levels regularly while using this medicine.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Mylamin GN Tablet with or without food. Never take more than the prescribed dose. Take this tablet at around the same time daily. Do not stop taking this tablet unless your doctor tells you to stop.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Causes sleepiness

How it works
Mylamin GN Tablet works by changing the activity of chemicals called neurotransmitters in the brain, which send messages between nerve cells. Thus, it reduces pain messages arriving in the brain causing pain reduction.
Legal Status

Unknown

Unknown

Unknown

Unknown

Classification

Category

Gamma-aminobutyric acid analogs, Tricyclic antidepressants

Schedule

Schedule H

Drugbank.ca. 2021. Gabapentin | DrugBank Online. [online] Available at: < [Accessed 7 April 2021].

https://www.drugbank.ca/drugs/DB00996>

Dailymed.nlm.nih.gov. 2021. DailyMed - NORTRIPTYLINE HYDROCHLORIDE capsule. [online] Available at: < [Accessed 7 April 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b58d473a-b19f-4d2a-b1ae-dd398d7a29e1>

Pubchem.ncbi.nlm.nih.gov. 2021. Nortriptyline. [online] Available at: < [Accessed 12 April 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Nortriptyline>

Go.drugbank.com. 2021. Nortriptyline | DrugBank Online. [online] Available at: < [Accessed 12 April 2021].

https://go.drugbank.com/drugs/DB00540>

Pubchem.ncbi.nlm.nih.gov. 2021. Gabapentin. [online] Available at: < [Accessed 12 April 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Gabapentin>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 12 Apr 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.